CompletedNCT01514422
Minocycline Added to Mood Stabilizers for Depression Related to Bipolarity
Medication studyAges 18–68United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 68 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateMay 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 68 Years
- Official registry ID
- NCT01514422
- Official title
Show the full official title
Minocycline for Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Icahn School of Medicine at Mount Sinai, a university.
Did this study involve medication?
Yes. The study involved medication, including Minocycline.
Who was this study for?
Listed age limits: 18 years to 68 years.
